As of 10:30 AM on the 19th, Seegene is trading at 275,700 KRW, up 4.63% from the previous day. The trading volume is 2,435,124 shares, which is 34.61% of the previous day's volume. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.

On August 14, Shinhan Financial Investment's researcher Yoon Chang-min announced a target price of 320,000 KRW for Seegene, stating "Q2 operating profit recorded 169 billion KRW (+3,540% YoY)."

Over the past five days, individual investors have net purchased 139,188 shares of Seegene, while foreigners and institutions have net purchased 23,916 shares and net sold 167,978 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing